E Gibbs
Overview
Explore the profile of E Gibbs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1053
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Itchins M, Arena J, Nahm C, Rabindran J, Kim S, Gibbs E, et al.
Eur J Surg Oncol
. 2017 Jul;
43(9):1711-1717.
PMID: 28688722
Background: Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease. Neoadjuvant therapy (NA) with chemotherapy (NAC) and radiotherapy (RT) prior to surgery provides promise. In the absence of prospective data, well...
2.
Roncolato F, Gibbs E, Lee C, Asher R, Davies L, Gebski V, et al.
Ann Oncol
. 2017 Jun;
28(8):1849-1855.
PMID: 28595285
Background: Women with platinum-resistant ovarian cancer are a heterogeneous group whose median overall survival is 12 months. We hypothesized that their quality of life (QoL) scores would be prognostic. Patients...
3.
Bamias A, Gibbs E, Khoon Lee C, Davies L, Dimopoulos M, Zagouri F, et al.
Ann Oncol
. 2017 May;
28(8):1842-1848.
PMID: 28481967
Background: In the open-label randomized phase III AURELIA trial, adding bevacizumab to chemotherapy for platinum-resistant ovarian cancer (PROC) significantly improved progression-free survival and response rate versus chemotherapy alone, but not...
4.
Bar-Or A, Oger J, Gibbs E, Niino M, Aziz T, Renoux C, et al.
Mult Scler
. 2009 Aug;
15(8):959-64.
PMID: 19667022
Background: Although the concept that an initial course of immune-suppression facilitates subsequent immune-modulation (such as Th1 to Th2 deviation) is attractive for several autoimmune diseases, such a mechanism for serial-combination...
5.
Gibbs E, Tremlett H, Ball N, Hashimoto S
Eur J Neurol
. 2008 Jan;
15(1):e4.
PMID: 18171383
No abstract available.
6.
Boz C, Oger J, Gibbs E, Grossberg S
Mult Scler
. 2007 Oct;
13(9):1127-37.
PMID: 17967840
Multiple sclerosis (MS) patients treated with interferon-beta (IFN-beta) often form anti-IFN-beta antibodies accompanied by a reduction in IFN-beta bioavailability. The clinical effect of these antibodies remains controversial. MS patients in...
7.
Bates P, Getz B, Gibbs E, NEU L, Pobursky J
Urol Nurs
. 2002 May;
20(2):109-10, 115-6; quiz 117-8.
PMID: 11998121
Nurses who work with patients with interstitial cystitis agree these patients demand considerable clinician time. Interstitial cystitis is a chronic disease with several etiologic theories explaining the syndrome. Diagnosis and...
8.
Hanlon J, Suggit R, Gibbs E, McMeeking R, Love J
J Heart Valve Dis
. 2000 Jan;
8(6):609-13.
PMID: 10616236
Background And Aim Of The Study: A novel geometric trefoil pattern has been suggested for semilunar valve reconstruction. Optimization of the geometry must rely on an appreciation of normal anatomy...
9.
Zhang G, Gibbs E, Kelman Z, ODonnell M, Hurwitz J
Proc Natl Acad Sci U S A
. 1999 Mar;
96(5):1869-74.
PMID: 10051561
Proliferating cell nuclear antigen (PCNA) is a processivity factor required for DNA polymerase delta (or epsilon)-catalyzed DNA synthesis. When loaded onto primed DNA templates by replication factor C (RFC), PCNA...
10.
Cai J, Yao N, Gibbs E, Finkelstein J, Phillips B, ODonnell M, et al.
Proc Natl Acad Sci U S A
. 1998 Sep;
95(20):11607-12.
PMID: 9751713
Human replication factor C (hRFC) is a five-subunit protein complex (p140, p40, p38, p37, and p36) that acts to catalytically load proliferating cell nuclear antigen onto DNA, where it recruits...